1. Home
  2. TNON vs ALZN Comparison

TNON vs ALZN Comparison

Compare TNON & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenon Medical Inc.

TNON

Tenon Medical Inc.

HOLD

Current Price

$0.91

Market Cap

4.8M

Sector

Health Care

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

HOLD

Current Price

$0.88

Market Cap

5.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNON
ALZN
Founded
2012
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
5.5M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
TNON
ALZN
Price
$0.91
$0.88
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $6.00
N/A
AVG Volume (30 Days)
★ 95.4K
39.2K
Earning Date
11-12-2026
12-08-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 84.90
76.77
EPS
N/A
★ N/A
Revenue
★ $3,944,000.00
N/A
Revenue This Year
$44.38
N/A
Revenue Next Year
$39.49
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 20.35
N/A
52 Week Low
$0.96
$0.84
52 Week High
$40.95
$2.54

Technical Indicators

Market Signals
Indicator
TNON
ALZN
Relative Strength Index (RSI) 22.15 24.65
Support Level N/A $0.84
Resistance Level $4.18 $1.29
Average True Range (ATR) 0.17 0.17
MACD -0.02 -0.04
Stochastic Oscillator 4.65 1.25

Price Performance

Historical Comparison
TNON
ALZN

About TNON Tenon Medical Inc.

Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.

Share on Social Networks: